Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
6.75/7.50
|
|
Enterprise Value
19.47B
|
| Balance Sheet |
|
Book Value Per Share
42.42
|
| Cash Flow |
|
Cash Flow Yield
0.04
|
| Income Statement |
|
Total Revenue
2.89B
|
|
Operating Revenue Per Share
40.68
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/11/15 08:35 EST
Industry overview quotes are at least 15 minutes delayed
|
Business Description
|
|||
| West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States. |

261.36 
